Aromatase activating agent

a technology of activating agent and aromatase, which is applied in the direction of algae medical ingredients, drug compositions, metabolic disorders, etc., can solve the problems that direct administration is not appropriate for prevention or amelioration, and achieve the effect of prevention, amelioration or treatmen

Inactive Publication Date: 2007-02-22
KAO CORP
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Meanwhile, estrogen or estrogen-like substances are endocrine disruptors, and therefore, their direct administration is not appropriate for the prevention or amelioration of the above-mentioned symptoms or lesions.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

production example 1

Production of Mulberry Bark Extract

[0030] Mulberry bark (10 g) was subjected to extraction with an aqueous ethanol solution (50 v / v %, 25 mL) for about seven days at room temperature, followed by filtration, to thereby yield a mulberry bark extract (yield: 11 mL, evaporation residue: 11.6 w / v %).

production example 2

[0031] Extracts of the plants and chlorella listed in Table 1 below were prepared in accordance with the process of Production Example 1.

TABLE 1Portion subjectedSolvent employedPlantto extractionfor extractionGinsengRoot90% EthanolCucumberImmature fruit40% 1,3-ButanediolPhellodendron barkBark50% EthanolChlorellaWhole algaeWater

referential example 1

Construction of Reporter Gene Assay System

[0032] Genomic DNA was extracted from a human normal keratinocyte sample. A DNA fragment in the genomic DNA, the fragment containing a transcriptional control region of human aromatase gene exon 1c and a portion of the exon 1c, was amplified through PCR by use of the following primers.

upper primer5′-GACTAGTAAACAACCACAAAACTGCTC-3′(SEQ ID NO: 1)lower primer5′-AACTGCAGACAAGTCAAAACAAGGAAGC-3′(SEQ ID NO: 2)

[0033] The PCR product was treated with restriction enzymes SpeI and PstI, and the product was transferred into a SeaPansy null control vector (TOYO INK MFG. CO., LTD.) at SpeI and PstI sites thereof. The product was used as an Ex1c-luc plasmid in the luciferase assay described below.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention is directed to an aromatase activating agent containing a plant selected from among mulberry bark, ginseng, cucumber, and phellodendron bark; or chlorella; or an extract of any of these ingredients. The aromatase activating agent of the present invention is highly safe to the human body, and useful as a drug or cosmetic composition for prevention, amelioration, or treatment of various lesions caused by estrogen deficiency.

Description

BACKGROUND OF THE INVENTION [0001] 1. Field of the Invention [0002] The present invention relates to an aromatase activating agent which augments activity of aromatase, an enzyme which biosynthesizes estrogen from androgen. [0003] 2. Background Art [0004] Estrogen represents a class of female hormones which, in humans, are produced primarily in the ovaries. Some known members falling under estrogen are 17β-estradiol, estrone, and estriol. [0005] Estrogen participates in a variety of physiological functions, such as proliferation of the endometrium, and regulation of sexual functions, bone metabolism, and lipid metabolism. Therefore, when the level of estrogen in the body drops with ageing and ovarian functions deteriorate, a variety of pathological conditions are induced, such as menopause symptoms, hypogonadism, autonomic imbalance, lipid metabolism abnormality, vasomotor instability, and osteoporosis. [0006] Meanwhile, estrogen or estrogen-like substances are endocrine disruptors,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K36/254A61K36/42A61K36/02A61K8/96A61K8/97A61K8/99A61K36/00A61K36/05A61K36/23A61K36/258A61K36/28A61K36/60A61K36/75A61K36/756A61P3/06A61P9/00A61P15/00A61P19/00A61P19/10A61P25/00A61P43/00
CPCA61K8/97A61K36/05A61K36/258A61K36/28A61K36/42A61K36/756A61Q19/00A61K8/9722A61K8/9789A61P3/06A61P9/00A61P15/00A61P19/00A61P19/10A61P25/00A61P43/00
Inventor KAKUO, SHINGOMORIWAKI, SHIGERUOHUCHI, ATSUSHIKUSUOKU, HIROSHI
Owner KAO CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap